Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.

MLA

Pak, Linda M., et al. “Prospective Phase II Trial of Combination Hepatic Artery Infusion and Systemic Chemotherapy for Unresectable Colorectal Liver Metastases: Long Term Results and Curative Potential.” Journal of Surgical Oncology, vol. 117, no. 4, Mar. 2018, pp. 634–43. EBSCOhost, https://doi.org/10.1002/jso.24898.

APA

Pak, L. M., Kemeny, N. E., Capanu, M., Chou, J. F., Boucher, T., Cercek, A., Balachandran, V. P., Kingham, T. P., Allen, P. J., DeMatteo, R. P., Jarnagin, W. R., & D’Angelica, M. I. (2018). Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential. Journal of Surgical Oncology, 117(4), 634–643. https://doi.org/10.1002/jso.24898

Chicago

Pak, Linda M., Nancy E. Kemeny, Marinela Capanu, Joanne F. Chou, Taryn Boucher, Andrea Cercek, Vinod P. Balachandran, et al. 2018. “Prospective Phase II Trial of Combination Hepatic Artery Infusion and Systemic Chemotherapy for Unresectable Colorectal Liver Metastases: Long Term Results and Curative Potential.” Journal of Surgical Oncology 117 (4): 634–43. doi:10.1002/jso.24898.